Tetrahydrozoline Poisoning: Clinical Manifestations
Tetrahydrozoline poisoning presents with a characteristic toxidrome of CNS depression, bradycardia, hypotension, hypothermia, and respiratory depression—symptoms that can be life-threatening, particularly in children, and may persist for 24-36 hours.
Primary Clinical Features
The hallmark manifestations of tetrahydrozoline poisoning result from its alpha-adrenergic agonist activity on central receptors 1, 2, 3:
Cardiovascular Effects
- Bradycardia (most consistent finding)
- Hypotension (borderline to severe)
- Complete heart block (reported in severe cases) 4
- QT prolongation 4
- Chest pain 3
Central Nervous System Effects
- Altered mental status ranging from lethargy to coma 1, 2
- CNS depression with respiratory compromise 3
- Miosis (pinpoint pupils) 3
- Intermittent periods of consciousness 5
Other Manifestations
- Hypothermia (can persist for approximately 24 hours) 2
- Pale, cold skin 2
- Irregular, superficial respirations 2
- Vomiting (particularly post-exposure) 5
Time Course and Severity
Symptom onset is typically rapid (15-90 minutes post-ingestion), with effects persisting for 24-36 hours in severe cases 1, 6. The calculated half-life is approximately 4.4 hours 1.
Dose-Dependent Toxicity
- Small children are at highest risk from even minimal ingestions 2
- As little as 7.5 mL of eye drops can cause severe toxicity requiring ICU admission 1
- Adult cases with massive ingestion (120 mL) have resulted in complete heart block 4
Critical Clinical Pitfalls
The severity of presentation does not always correlate with time since ingestion—some patients present asymptomatically but deteriorate 90 minutes later, while others become lethargic within 15 minutes and require immediate intubation 1. This unpredictable progression mandates:
- All suspected ingestions require ICU-level monitoring for at least 24 hours
- Cardiovascular effects may be prolonged (up to 36 hours) 6
- Hypothermia can be refractory to passive warming measures 2
Diagnostic Considerations
Tetrahydrozoline can be detected in urine up to 20 hours post-exposure at concentrations around 100-150 ng/mL using GC-MS 5. Blood levels may be undetectable even when urine is positive 5.
The clinical presentation mimics opioid toxicity (CNS depression, miosis, respiratory depression, bradycardia), but the mechanism is distinct—tetrahydrozoline acts via central alpha-adrenergic receptor stimulation rather than opioid receptor binding 3.
Management Implications
Symptomatic bradycardia may require atropine administration 2. Mechanical ventilation may be necessary for respiratory depression 1. The FDA label warns that ingestion can be life-threatening, particularly in children, and advises immediate contact with Poison Control (1-800-222-1222) 7.
Recognition of this toxidrome is essential because tetrahydrozoline is widely available in over-the-counter eye drops and nasal decongestants, with over 1,600 oral exposures reported annually to U.S. poison centers 6. Cases of intentional poisoning for drug-facilitated assault have been documented 5, expanding the clinical contexts in which this poisoning should be considered.